- The study focused on trans-arterial embolization for treating inflammatory musculoskeletal conditions, analyzing 19 studies with a total of 394 participants following PRISMA guidelines.
- Common conditions treated included knee osteoarthritis and adhesive capsulitis, with most studies reporting significant pain reduction lasting up to four years and only temporary adverse effects.
- Although the early findings suggest promising efficacy and safety, the authors emphasize the need for more rigorous randomized, placebo-controlled trials to strengthen the evidence.